Harris Todd's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Jun 15, 2023
- Accession no.
- 0001209191-23-037613
- Filed
- Jun 15, 2023
- Trade date
- Jun 13-15, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $332.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Harris ToddCIK 0001711463 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Common Stock | MOption exerciseAcquired | +7,927 | $2.25 | +$17,835.75 | 1,709,203 | Direct | |
| Jun 13, 2023 | Common Stock | SSaleDisposed | −7,927 | $16.00F2 | −$126,832 | 1,701,276 | Direct | |
| Jun 15, 2023 | Common Stock | MOption exerciseAcquired | +12,773 | $2.25 | +$28,739.25 | 1,714,049 | Direct | |
| Jun 15, 2023 | Common Stock | SSaleDisposed | −12,773 | $16.13F3 | −$206,028.49 | 1,701,276 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Common Stock | MOption exerciseDisposed | −7,927 | $0.00 | $0 | 389,610 | Direct | |
| Jun 15, 2023 | Common Stock | MOption exerciseDisposed | −12,773 | $0.00 | $0 | 376,837 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.60. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.